Texas Permanent School Fund’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-36,855
Closed -$1.55M 1467
2024
Q1
$1.55M Buy
36,855
+978
+3% +$38.1K 0.01% 1170
2023
Q4
$1.37M Buy
35,877
+167
+0.5% +$5.56K 0.01% 1202
2023
Q3
$1.1M Buy
35,710
+256
+0.7% +$8.83K 0.01% 1210
2023
Q2
$1.12M Buy
35,454
+185
+0.5% +$6.34K 0.01% 1223
2023
Q1
$1.29M Buy
35,269
+8,575
+32% +$300K 0.01% 1155
2022
Q4
$790K Sell
26,694
-1,527
-5% -$49.1K 0.01% 1211
2022
Q3
$1.1M Buy
28,221
+674
+2% +$30.9K 0.02% 1057
2022
Q2
$1.06M Buy
27,547
+767
+3% +$29.2K 0.02% 1097
2022
Q1
$1.3M Sell
26,780
-454
-2% -$23.4K 0.02% 1070
2021
Q4
$2M Sell
27,234
-603
-2% -$49.5K 0.02% 911
2021
Q3
$2.54M Buy
27,837
+18,001
+183% +$1.53M 0.03% 754
2021
Q2
$618K Buy
+9,836
New +$364K 0.01% 1372

Other funds holding ASTH

Texas Permanent School Fund's ASTH Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Astrana Health (ASTH) in Q2 2024, closing a stake of 36,855 shares — an estimated $1.55M sold.

Texas Permanent School Fund first reported a position in ASTH in Q2 2021 and held it in 12 quarters. The position peaked at $2.54M in Q3 2021. 172 funds tracked by Wall St. Rank hold ASTH as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Astrana Health position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 36,855 Astrana Health shares in Q2 2024, an estimated $1.55M.
  • Texas Permanent School Fund first reported a position in Astrana Health in Q2 2021 and held it in 12 quarters.
  • Texas Permanent School Fund's Astrana Health position peaked at $2.54M in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Astrana Health as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.